GemPharmatech Co., Ltd. Class A

GemPharmatech Co., Ltd. Class A financial statements

GemPharmatech Co., Ltd. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueCNY 793.39MEODHD
Net incomeCNY 142.64MEODHD
Cash and equivalentsCNY 486.62MEODHD

GemPharmatech Co., Ltd. Class A financials on 6ix · GemPharmatech Co., Ltd. Class A on 6ix